Elizabeth Lopatto
Bloomberg
November 13, 2009
Batches of Genzyme Corp.’s treatments for rare genetic disorders may be contaminated with steel fragments, non-latex rubber, and fiber-like materials from the manufacturing process, according to U.S. regulators.
Medicines affected include...